Blood Coagulation

You have accessRestricted Access
Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease
Katherine G. Garlo, David J.R. Steele, Sagar U. Nigwekar and Kevin E. Chan

CJASN January 2019, 14 (1) 125-136; DOI: https://doi.org/10.2215/CJN.06430518

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
Paul M. Palevsky

CJASN November 2016, 11 (11) 2078; DOI: https://doi.org/10.2215/CJN.09700916

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con
Vaibhav Keskar and Manish M. Sood

CJASN November 2016, 11 (11) 2085-2092; DOI: https://doi.org/10.2215/CJN.03200316

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Charles A. Herzog

CJASN November 2016, 11 (11) 2095-2096; DOI: https://doi.org/10.2215/CJN.09470916

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
Nisha Bansal

CJASN November 2016, 11 (11) 2093-2094; DOI: https://doi.org/10.2215/CJN.08610816

Add to Selected Citations